Raymond James Financial Services Advisors, Inc. Entasis Therapeutics Holdings Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$1.61 - $2.85 $55,656 - $98,521
-34,569 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$2.04 - $4.03 $24,212 - $47,832
11,869 Added 52.29%
34,569 $71,000
Q2 2020

Jul 17, 2020
BUY
$2.31 - $3.32 $5,775 - $8,300
2,500 Added 12.38%
22,700 $67,000
Q1 2020

Apr 21, 2020
BUY
$1.99 - $5.56 $3,980 - $11,120
2,000 Added 10.99%
20,200 $53,000
Q4 2019

Feb 12, 2020
SELL
$4.6 - $6.28 $252 - $345
-55 Reduced 0.3%
18,200 $90,000
Q3 2019

Nov 07, 2019
BUY
$5.12 - $8.47 $93,465 - $154,619
18,255 New
18,255 $109,000

About Entasis Therapeutics Holdings Inc.

ETTX Quotes by TradingView
  • Ticker ETTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,851,800
  • Market Cap $105M
More about ETTX
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email